Abstract
Pain may be classified as nociceptive or neuropathic and somatic or visceral. Neuropathic pain can be further subdivided into that due to nerve compression, nerve destruction or sympathetically maintained pain. The chapter describes the assessment and diagnosis of the cause of pain and the concepts of total pain and regular and breakthrough pain. Management starts with explanation and general non-drug measures. Disease modification runs alongside the use of non-opioid analgesics and then the WHO opioid ladder. Oral morphine is the main strong opioid used, but the indication for alternative drugs and routes is considered. Neuropathic pain usually requires the use of adjuvant analgesics. The role of other adjuvants in certain circumstances is described as well as the use of topical analgesics and anesthetic interventions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blinderman CD, Homel P, Billings P, et al. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage. 2009;38(1):115–23.
Lohne V, Heer HC, Anderson M, et al. Qualitative study of pain of patients with chronic obstructive pulmonary disease. Heart Lung. 2010;39(3):226–34.
Borge CR, Wahl AK, Moum T. Association of breathlessness with multiple symptoms in chronic obstructive pulmonary disease. J Adv Nurs. 2010;66(12):2688–700.
Portenoy RK, Miransky J, Thaler HT, et al. Pain in ambulatory patients with lung or colon cancer. Cancer. 1992;70(6):1616–24.
Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. J Am Geriatr Soc. 2000;48(5):146–53.
Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985–91.
Foley KM. How well is cancer pain treated? Palliat Med. 2011;25(5):398–401.
Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996;64:107–14.
Stute P, Soukup J, Menzel M, Sabatowski R, Grond S. Analysis and treatment of different types of neuropathic cancer pain. J Pain Symptom Manage. 2003;26(6):1123–31.
von der Lippe B, Sandven P, Brubakk O. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB) – a report of ten cases. J Infect. 2006;52(2):92–6.
Lema MJ, Foley KM, Hausheer FH. Types and epidemiology of cancer-related neuropathic pain: the intersection of cancer pain and neuropathic pain. Oncologist. 2010;15 Suppl 2:3–8.
Blumenthal DT, Blumenthal DT. Assessment of neuropathic pain in cancer patients. Curr Pain Headache Rep. 2009;13(4):282–7.
Desbiens NA, Wu AW, Broste SK, Wenger NS, Connors Jr AF, Lynn J, Yasui Y, Phillips RS, Fulkerson W. Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations. Crit Care Med. 1996;24(12):1953–61.
Brevik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment and patient attitudes. Ann Oncol. 2009;20:1420–33.
Clayton HA, Reschak GLC, Gaynor SE, Creamer JL. A novel program to assess and manage pain. Medsurg Nurs. 2000;9(6):318–22.
WHO pain ladder.www.who.int/cancer/palliative/painladder/en/index.html. Accessed 30 Nov 2011.
McQuay H. Evidence-based medicine: what is the evidence that it has made a difference? Palliat Med. 2011;25(5):394–7.
Wilkinson S, Barnes K, Storey L. Massage for symptom relief in patients with cancer: systematic review. J Adv Nurs. 2008;63(5):430–9.
Paley CA, Johnson MI, Tashani OA, Bagnall AM. Acupuncture for cancer pain in adults. Cochrane Database Syst Rev. 2011;(1):CD007753. doi:10.1002/14651858.CD007753.pub2.
Robb KA, Bennett MI, Johnson MI, Simpson KJ, Oxberry SG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev. 2008;(3):CD006276. doi:10.1002/14651858.CD006276.pub2.
Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol. 1972;240(102):200–3.
Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12(1):46–55.
Axelsson B, Christensen S. Is there an additive analgesic effect of paracetamol at step 3? A double-blind randomised controlled study. Palliat Med. 2003;17:724–5.
Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol. 2004;22(16):3389–94.
Buria M, Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther. 2005;107:139–54.
Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002;53:25–57.
Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520–8.
Finckh A, Aronson MD. Cardiovascular risks of cyclooxygenase-2 inhibitors: where do we stand now? Ann Intern Med. 2005;142:212–4.
Topol EJ. Arthritis medicines and cardiovascular events – “house of coxibs”. J Am Med Assoc. 2005;293:366–8.
Rostom A, Dube C, Wells GA, Tugwell P, Welch V, Jolicoeur E, McGowan J, Lanas A. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev. 2002;(4):CD002296. doi:10.1002/14651858.CD002296.
Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspiring induced asthma and its implications for clinical practice. Br Med J. 2004;328:434.
Venturini C, Isakson P, Needleman P. Nonsteroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclooxygenase isoforms. Curr Opin Nephrol Hypertens. 1998;7(1):79–82.
Schneider V, Lévesque L, Zhang B, Hutchinson T, Brophy JM. Association of selective and conventional nonsteroidal anti-inflammatory drugs with acute renal failure: a population based, nested case–control analysis. Am J Epidemiol. 2006;164(9):881–9.
Twycross R, Wilcock A, editors. PCF4 – Palliative care formulary. 4th ed. Nottingham: palliativedrugs.com; 2011. p. 355.
Lewis KS, Han NH. Tramadol: a new centrally acting analgesic. Am J Health Syst Pharm. 1997;54(6):643–52.
Borgbjerg FM, Nielsen K, Franks J. Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain. 1996;64:123–8.
Wiffen PJ, McQuay HJ, Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2007;(4):CD003868. doi:10.1002/14651858.CD003868.pub2.
Mercadante S. Opioid titration in cancer pain: a critical review. Eur J Pain. 2007;11(8):823–30.
Radbruch L, Sabatowski R, Loick G, Kulbe C, Kasper M, Grond S, Lehmann KA. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med. 2000;14(2):111–9.
Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004;28(5):497–504.
Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain. 1999;79(1):15–20.
Twycross R, Wilcock A, editors. PCF4 – Palliative care formulary. 4th ed. Nottingham: palliativedrugs.com; 2011. p. 283.
Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain. 1999;80:453–62.
Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454. doi:10.1002/14651858.CD005454.pub2.
Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;(3):CD007938. doi:10.1002/14651858.CD007938.pub2.
Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;(3):CD007076. doi:10.1002/14651858.CD007076.pub2.
Mannix K, Ahmedzai SH, Anderson H, Bennett M, Lloyd-Williams M, Wilcock A. Using bisphosphonates to control the pain of bone metastases: evidence based guidelines for palliative care. Palliat Med. 2000;14:455–61.
Tytgat GN. Hyoscine butylbromide – a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin. 2008;24(11):3159–73.
Khaliq W, Alam S, Puri NK. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2007;(2):CD004846. doi:10.1002/14651858.CD004846.pub2.
Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2009;(4):CD007393. doi:10.1002/14651858.CD007393.pub2.
Massey T, Derry S, Moore RA, McQuay HJ. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev. 2010;(6):CD007402. doi:10.1002/14651858.CD007402.pub2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Grogan, E. (2013). Pain in Respiratory Disease. In: Bourke, S., Peel, E. (eds) Integrated Palliative Care of Respiratory Disease. Springer, London. https://doi.org/10.1007/978-1-4471-2230-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2230-2_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2229-6
Online ISBN: 978-1-4471-2230-2
eBook Packages: MedicineMedicine (R0)